Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Summit Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get SMMT alerts

About Robert Duggan

Robert Duggan is recorded as Board Member at Summit Therapeutics Inc. (SMMT) since January 1, 2019 and Chairman and CEO at Summit Therapeutics Inc. (SMMT). The newest filing on record that lists Robert Duggan as CEO and Board Member at Summit Therapeutics Inc. (SMMT) is dated April 17, 2026. The proxy statement of Summit Therapeutics Inc. reports total compensation of $172,376 for Robert Duggan in fiscal 2025. Disclosed compensation is on record for 7 fiscal years. Robert Duggan has spoken on 1 earnings call across 1 company, most recently for Summit Therapeutics Inc. on August 9, 2023. Summit Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Summit Therapeutics Inc. includes Glyn Edwards (CEO), Mahkam Zanganeh (CEO, COO and Board Member), Manmeet Soni (CFO and Board Member) and 7 others.

Robert Duggan on recent calls

“I'd like to say a few words about what our amazing team has accomplished, then I will hand it over to Maky to add more context and then Ankur will provide some updates regarding our financial positions and outlook.”
CEO, Summit Therapeutics Inc. Q2 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Summit Therapeutics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Summit Therapeutics Inc. (SMMT) — $172,376
2024 Summit Therapeutics Inc. (SMMT) — $158,613
2023 Summit Therapeutics Inc. (SMMT) — —
2022 Summit Therapeutics Inc. (SMMT) — —
2021 Summit Therapeutics Inc. (SMMT) — —
2020 Summit Therapeutics Inc. (SMMT) — —
2019 Summit Therapeutics Inc. (SMMT) — —

Recent activity